Breaking News Instant updates and real-time market news.

WHR

Whirlpool

$182.85

0.39 (0.21%)

, ARNC

Arconic

$25.05

-2.12 (-7.80%)

13:05
10/23/17
10/23
13:05
10/23/17
13:05

Notable companies reporting after market close

Notable companies reporting after the market close, with earnings consensus, include Whirlpool (WHR), consensus $3.94... Arconic (ARNC), consensus 27c... Zions Bancorpor (ZION), consensus 73c... Crane (CR), consensus $1.10... Owens-Illinois (OI), consensus 74c... Rambus (RMBS), consensus 17c.

WHR

Whirlpool

$182.85

0.39 (0.21%)

ARNC

Arconic

$25.05

-2.12 (-7.80%)

ZION

Zions Bancorp

$46.76

0.71 (1.54%)

CR

Crane

$84.02

-0.09 (-0.11%)

OI

Owens-Illinois

$25.35

-0.24 (-0.94%)

RMBS

Rambus

$13.70

0.12 (0.88%)

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 14

    Nov

  • 07

    Dec

WHR Whirlpool
$182.85

0.39 (0.21%)

07/20/17
JPMS
07/20/17
NO CHANGE
JPMS
Whirlpool pullback on Amazon-Sears team-up overdone, says JPMorgan
JPMorgan analyst Michael Rehaut said he believes the decline in Whirlpool (WHR) following news of Sears' (SHLD) deal to sell appliances via Amazon (AMZN) has been overdone. He notes Whirlpool has proven it can adapt to the changing retail environment and that if Amazon becomes a reasonably large distribution channel for appliances he'd expect the company to participate.
07/28/17
RBCM
07/28/17
NO CHANGE
RBCM
Whirlpool should be bought on weakness, says RBC Capital
RBC Capital analyst Robert Wetenhall says that Whirplool's guidance cut was caused by "near-term headwinds." He believes that the company's competitive position and free cash flow remain strong, while the current valuation has created an attractive entry point. The analyst recommends buying the shares on weakness.
10/06/17
MKMP
10/06/17
NO CHANGE
Target $177
MKMP
Neutral
Some impact of ITC decision on Whirlpool largely priced in, says MKM Partners
MKM Partners analyst Megan McGrath says that while the latest ITC ruling in favor of Whirlpool and against South Korean manufacturers of washing machines is a "general positive" for at least a year, the 10% run-up in stock since late August has priced in some of the good news. There are still uncertainties around the remedy from the ITC decision as well as response from the competition, writes McGrath in her research note, adding that she remains cautious on the company's execution in Europe and the headwinds from steel price inflation. The analyst maintains her Neutral rating and $177 price target on Whirlpool.
06/22/17
FBCO
06/22/17
INITIATION
Target $208
FBCO
Neutral
Whirlpool initiated with a Neutral at Credit Suisse
Credit Suisse analyst Susan Maklari initiated Whirlpool with a Neutral and a $208 price target saying margin pressure from rising raw material costs, increasing competition, and the changing consumer environment keep risk/reward less attractive.
ARNC Arconic
$25.05

-2.12 (-7.80%)

08/22/17
LBOW
08/22/17
UPGRADE
LBOW
Buy
Arconic upgraded to Buy from Neutral at Longbow
07/10/17
07/10/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. FLIR Systems (FLIR) upgraded to Strong Buy from Market Perform at Raymond James. 2. HP Inc. (HPQ) upgraded to Buy from Neutral at Mizuho. 3. PayPal (PYPL) upgraded to Outperform from Market Perform at Bernstein with analyst Lisa Ellis saying the company is "at the beginning, not the end, of multi-year outperformance supported by high-teens earnings appreciation." 4. Arconic (ARNC) upgraded to Overweight from Neutral at JPMorgan with analyst Seth Seifman citing valuation with the stock underperforming the S&P 500 Index by 15% over the past month. 5. Cavium (CAVM) upgraded to Buy from Hold at Jefferies with analyst Mark Lipacis saying the company will benefit as the industry undergoes a "tectonic shift towards a parallel computing model." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
07/10/17
JPMS
07/10/17
UPGRADE
Target $28
JPMS
Overweight
Arconic upgraded to Overweight from Neutral at JPMorgan
JPMorgan analyst Seth Seifman upgraded Arconic to Overweight citing valuation with the stock underperforming the S&P 500 Index by 15% over the past month. The analyst sees value in the shares even after cutting his estimates "significantly." He lowered his price target for the shares to $28 from $30.
07/13/17
GHSC
07/13/17
UPGRADE
Target $27
GHSC
Buy
Arconic upgraded to Buy from Neutral at Seaport Global
Seaport Global analyst Josh Sullivan upgraded Arconic to Buy and established a $27 price target saying the Grenfell fire liability is factored in shares and the core aerospace verticals, automotive sheet, and IGT are on track.
ZION Zions Bancorp
$46.76

0.71 (1.54%)

09/08/17
BARD
09/08/17
UPGRADE
BARD
Neutral
Zions Bancorp upgraded to Neutral from Underperform at Baird
10/02/17
BARD
10/02/17
DOWNGRADE
Target $43
BARD
Underperform
Zions Bancorp downgraded to Underperform at Baird
As reported previously, Baird analyst David George downgraded Zions Bancorp to Underperform from Neutral based on valuation. The analyst sees the need for accelerating loan growth and improvement in operating leverage to further narrow the spread in core returns versus peers. George has a $43 price target on Zions Bancorp shares.
10/02/17
BARD
10/02/17
DOWNGRADE
BARD
Underperform
Zions Bancorp downgraded to Underperform from Neutral at Baird
08/28/17
RHCO
08/28/17
NO CHANGE
RHCO
Texas bank weakness creates buying opportunity, says SunTrust
SunTrust analyst Jennifer Demba predicts that the flooding in Texas will negatively impact the stocks of banks based in the state. She thinks that the "probable" weakness of the following bank stocks will create buying opportunities: Zions Bancorp (ZION), Cullen/Frost (CFR), Prosperity Bancshares (PB), and Texas Capital (TCBI).
CR Crane
$84.02

-0.09 (-0.11%)

07/26/17
OPCO
07/26/17
NO CHANGE
Target $88
OPCO
Outperform
Crane selloff creates opportunity, says Oppenheimer
Oppenheimer analyst Jim Giannakouros says Crane's selloff after the company reported an in-line quarter creates opportunity. The analyst sees Crane as well positioned to be a growth and margins/returns outlier within his coverage given solid market positions and an execution track record. Giannakouros reiterated an Outperform rating on the stock but lowered his price target on the shares to $88 from $90.
07/11/17
WOLF
07/11/17
INITIATION
WOLF
Peer Perform
Crane initiated with a Peer Perform at Wolfe Research
08/14/17
WOLF
08/14/17
UPGRADE
WOLF
Outperform
Crane upgraded to Outperform from Peer Perform at Wolfe Research
07/26/17
BOFA
07/26/17
NO CHANGE
Target $90
BOFA
Buy
Crane pullback overdone, says BofA/Merrill
BofA/Merrill analyst Kristine Liwag said Crane weakness attributed to a more conservative tone in guidance regarding its ability to hit the high-end of 2017 guidance of $4.35-$4.55 is overdone. Liwag said there is no significant change in end-market outlook and continues to expect strong operating leverage in Fluid Handling to drive earnings in 2018 and beyond. The analyst rates Crane a Buy with a $90 price target.
OI Owens-Illinois
$25.35

-0.24 (-0.94%)

09/05/17
UBSW
09/05/17
INITIATION
Target $26
UBSW
Neutral
Owens-Illinois initiated with a Neutral at UBS
UBS analyst Edlain Rodriguez started Owens-Illinois with a Neutral rating and $26 price target. The analyst views the risk/reward as fairly balanced at current valuation levels.
04/26/17
SBSH
04/26/17
NO CHANGE
Target $26
SBSH
Buy
Owens-Illinois turnaround remains on track, says Citi
Citi analyst Anthony Pettinari raised his price target for Owens-Illinois to $26 from $24 following the company's Q1 results. Owens' operational turnaround remains on track, Pettinari tells investors in a post-earnings research note. He views the shares as undervalued and keeps a Buy rating on the name.
09/05/17
09/05/17
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Owens-Illinois (OI) initiated with a Neutral at UBS. 2. Akamai (AKAM) initiated with a Neutral at Credit Suisse. 3. Zealand Pharma (ZEAL) was initiated with a Buy at Needham and Guggenheim while being initiated with an Overweight at Morgan Stanley. 4. YogaWorks (YOGA) was initiated with an Outperform at Cowen, an Overweight at Stephens, and a Buy at Roth Capital and Guggenheim. 5. Red Hat (RHT) initiated with a Neutral at Credit Suisse. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
RMBS Rambus
$13.70

0.12 (0.88%)

09/22/17
JPMS
09/22/17
DOWNGRADE
Target $15
JPMS
Neutral
Rambus downgraded to Neutral from Overweight at JPMorgan
JPMorgan analyst Paul Coster downgraded Rambus to Neutral citing a lack of catalysts following the company's analyst day. Coster still believes the shares are "somewhat undervalued" and keep a $15 price target on the name.
03/07/17
JPMS
03/07/17
NO CHANGE
Target $14.5
JPMS
Overweight
Rambus added to Analyst Focus List at JPMorgan
JPMorgan analyst Paul Coster added Rambus to his firm's U.S. Analyst Focus List as a near-term long idea. The 8.5% pullback since the company's Q4 results provides opportunity to buy this stock at a reasonable price, Coster tells investors in a research note. He sees good near-term revenue and earnings visibility and keeps an Overweight rating on Rambus with a $14.50 price target.
07/25/17
LOOP
07/25/17
NO CHANGE
Target $16
LOOP
Buy
Rambus undervalued with story still in early innings, says Loop Capital
Loop Capital analyst Betsy Van Hees said Rambus reported "a clean Q2 2017 beat across the board" and she noted that management said it believes Q3 revenue guidance and typical Q4 seasonal growth points to FY17 revenue slightly higher than the Street's consensus estimate. Van Hees, who sees Rambus as poised for strong earnings and revenue growth in 2017 and into 2018, believes the shares are undervalued and reiterates a Buy rating and $16 price target on the stock.
03/07/17
BNCH
03/07/17
NO CHANGE
Target $15
BNCH
Buy
Rambus license pact with Western Digital 'unique and intriguing,' says Benchmark
Benchmark analyst Gary Mobley called Rambus' (RMBS) newly-announced license agreement with Western Digital (WDC) "unique and intriguing," noting that Rambus memory patent licensing has historically been within the DRAM industry, not the NAND flash market. He believes the underpinnings of the agreement may relate to Rambus' ReRAM IP portfolio, and also finds it "interesting to note" that the agreement includes Rambus' security IP. Mobley has a Buy rating and $15 price target on Rambus shares.

TODAY'S FREE FLY STORIES

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

, PFE

Pfizer

$35.61

0.2648 (0.75%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Hot Stocks
FDA approves ViiV Healthcare's two drug HIV treatment Juluca »

The FDA today said it…

GSK

GlaxoSmithKline

$34.91

-0.21 (-0.60%)

PFE

Pfizer

$35.61

0.2648 (0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 07

    Dec

  • 14

    Dec

OCLR

Oclaro

$6.49

-0.09 (-1.37%)

14:05
11/21/17
11/21
14:05
11/21/17
14:05
Options
Oclaro call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 29

    Nov

  • 12

    Dec

NUE

Nucor

$56.02

0.46 (0.83%)

14:04
11/21/17
11/21
14:04
11/21/17
14:04
Hot Stocks
Nucor announces plans to build rebar micro mill »

Nucor announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

14:01
11/21/17
11/21
14:01
11/21/17
14:01
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:59
11/21/17
11/21
13:59
11/21/17
13:59
Recommendations
Cytokinetics analyst commentary  »

Cytokinetics price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

SSNLF

Samsung

, WHR

Whirlpool

$166.91

1.71 (1.04%)

13:58
11/21/17
11/21
13:58
11/21/17
13:58
Periodicals
ITC calls for tariff-rate quota on imported Samsung, LG washers, Reuters says »

The U.S. International…

SSNLF

Samsung

WHR

Whirlpool

$166.91

1.71 (1.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

RF

Regions Financial

$15.70

-0.16 (-1.01%)

13:55
11/21/17
11/21
13:55
11/21/17
13:55
Options
Regions Financial put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLMT

Calumet Specialty Products

$8.30

0.1 (1.22%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Hot Stocks
Calumet Specialty Products announces divestiture of Anchor Drilling Fluids »

Calumet Specialty…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITUS

ITUS

$3.16

0.25 (8.59%)

13:53
11/21/17
11/21
13:53
11/21/17
13:53
Conference/Events
ITUS to hold a pharmaceutical update conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ENBL

Enable Midstream

$15.03

-0.0315 (-0.21%)

13:49
11/21/17
11/21
13:49
11/21/17
13:49
Downgrade
Enable Midstream rating change  »

Enable Midstream…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

STLY

Stanley Furniture

$0.93

0.0349 (3.92%)

13:47
11/21/17
11/21
13:47
11/21/17
13:47
Hot Stocks
Stanley Furniture to sell substantially all its assets »

As previously reported,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:40
11/21/17
11/21
13:40
11/21/17
13:40
General news
NY Fed's overnight reverse repo totaled $42.9 B (19 counterparties) »

NY Fed's overnight…

EYE

National Vision

$30.19

0.21 (0.70%)

13:33
11/21/17
11/21
13:33
11/21/17
13:33
Initiation
National Vision initiated  »

National Vision initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Dec

CYTK

Cytokinetics

$11.10

-0.7 (-5.93%)

13:32
11/21/17
11/21
13:32
11/21/17
13:32
Downgrade
Cytokinetics rating change  »

Cytokinetics downgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

LOW

Lowe's

$81.59

0.13 (0.16%)

13:27
11/21/17
11/21
13:27
11/21/17
13:27
Recommendations
Lowe's analyst commentary  »

Lowe's price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

WHR

Whirlpool

$165.67

0.47 (0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Periodicals
ITC suggests tariffs on washing machine imports above 1.2M units, Bloomberg says »

Two of four ITC officials…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AWI

Armstrong World

$53.70

-0.15 (-0.28%)

13:25
11/21/17
11/21
13:25
11/21/17
13:25
Conference/Events
Armstrong World to hold a conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BMO

Bank of Montreal

$77.39

0.06 (0.08%)

13:21
11/21/17
11/21
13:21
11/21/17
13:21
Hot Stocks
BMO Financial Group enters partnership with CDL-Montreal »

BMO Financial Group and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

13:20
11/21/17
11/21
13:20
11/21/17
13:20
General news
Fed Governor Powell's hearings for the position as Fed Chair »

Fed Governor…

PG

Procter & Gamble

$88.93

0.66 (0.75%)

13:20
11/21/17
11/21
13:20
11/21/17
13:20
Options
Buyer lays out 500K for three month upside in Procter and Gamble »

Buyer lays out 500K for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

13:17
11/21/17
11/21
13:17
11/21/17
13:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

13:16
11/21/17
11/21
13:16
11/21/17
13:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CSX

CSX

$49.71

-0.21 (-0.42%)

13:05
11/21/17
11/21
13:05
11/21/17
13:05
Options
CSX call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

13:05
11/21/17
11/21
13:05
11/21/17
13:05
General news
FX Action: USD-JPY »

FX Action: USD-JPY…

SIG

Signet Jewelers

$54.67

-21.17 (-27.91%)

13:01
11/21/17
11/21
13:01
11/21/17
13:01
Downgrade
Signet Jewelers rating change  »

Wells Fargo downgrades…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

  • 07

    Dec

  • 08

    Dec

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.